Global Synthetic Peptides Market: Overview

Peptides are mainly made up of amino acid chains which are linked with each other with the peptide bond. For instance, dipeptides are formed by two amino acids, whereas tripeptides are made up of three amino acids. Polypeptides are an unbranched chain of amino acids which are joined by multiple peptide bonds. A chain which constitute 50 residues of amino acids are called peptides. On the other hand, an amino acid chain consisting more than 50 amino acids is known as proteins. Such peptides are mostly used as a therapeutic agent for treating various diseases condition. This is because of the peptides’ performability in various metabolic function in humans’ body. Synthetic peptides are a type of peptide which are mainly produced artificially – outside the cell through chemical reactions. These peptides are extensively used for various research purposes in several biotechnological and pharmaceutical companies. Such USPs are driving the global synthetic peptides market.

The global synthetic peptides market is mainly segmented on the basis of route of administration, application, distribution channel, marketing status and region. Under application, cardiovascular, oncology, hematological disorders, metabolic disorders, gastrointestinal disorders, dermatology, respiratory disorders, and others are the prominent segments comprising the market. Whereas, with respect to route of administration, key segments present in the global synthetic peptides market are parenteral and oral. In terms of distribution channel, the synthetic peptides market is segmented into retail pharmacies, hospital pharmacies, drug stores, online pharmacies, and others. Based on marketing status, the market is bifurcated into generics and branded.

Global Synthetic Peptides Market: Key Trends

Artificial peptide synthesis highly influences the production of a wide range of antibodies. Such artificial synthesis helps in inventing unique therapeutic techniques which are highly used for drug discovery, biological research, and product development. All such factors are fueling growth in the global synthetic peptides market. Various companies in the market are maintaining peptide libraries which further help in developing various types of vaccines, amino acid sequencing for research activities and drug screening. All these advantages are propelling expansion in the global synthetic peptides market.

Furthermore, rising demand for research and development for early detection and diagnosis of diseases, and growing prevalence of various metabolic disorders and cardiovascular disease are fueling demand in the global synthetic peptides market. Along with this, increasing healthcare expenditures and rising number of clinical trials using synthetic peptides, and rapid advancements in synthetic peptides for producing vaccines due to excellent specific are also boosting the global synthetic peptides market. Some other factors fueling growth in the global synthetic peptides market includes rapid technological advancements in the treatment and diagnostic process, mainly for infectious diseases and molecular techniques advancement.

Global Synthetic Peptides Market: Regional Outlook

With respect to geography, North America is leading the global synthetic peptides market as the region has witnessed rapid technological advancements in medicine field. Rising healthcare infrastructure, increasing prevalence of lifestyle diseases, and high drugs pricing are also responsible for fueling synthetic peptides market in this region. However, increasing number of multi-specialty hospitals and clinics and rising disposable incomes for expanding healthcare availability in Asia Pacific makes this region exhibit a substantially fast growth.

Global Synthetic Peptides Market: Competitive Landscape

Some of the prominent players operating in the global synthetic peptides market are Bachem Holding AG, Thermo Fisher Scientific, Teva Pharmaceutical Industries Ltd., and Novo Nordisk A/S. Each of these companies has been broadly described in the report in terms of prime strategies, revenue gained in recent times, and growth projected to attain in forthcoming years, in terms of market shares.

Leading segments of the global synthetic peptides market:


  • Oncology
  • Cardiovascular
  • Metabolic Disorders
  • Hematological Disorders
  • Gastrointestinal Disorders
  • Respiratory Disorders
  • Dermatology
  • Others

Route of administration

  • Parenteral
  • Oral

Marketing status

  • Branded
  • Generics

Distribution channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Drug Stores
  • Online Pharmacy
  • Others

This intelligence report by TMR is the outcome of intense study and rigorous assessment of various dynamics shaping the growth of the market. TMR nurtures a close-knit team of analysts, strategists, and industry experts who offer clients tools, methodologies, and frameworks to make smarter decisions. Our objective, insights, and actionable analytics provide CXOs and executives to advance their mission-critical priorities with confidence.

The scrutiny of the various forces impacting the dynamics of the market, and key and associated industries, guides enterprises in understanding various consumer propositions. Our clients leverage these insights and perspectives to enhance customer experience in the fast-paced business environment.

All our insights and perspectives are broadly based on 4 Pillars or Stages: ASBC-S, which offer an elaborate and customizable framework for the success of an organization. The essence and the roles of these in organizational successes are highlighted below:

  • Agenda for CXOs: TMR, through the study, sets the tone for agendas that are pertinent to CEOs, CFOs, CIOs, and other CXO executives of businesses operating in the market. The perspectives help our clients to bridge the gap between agenda and action plan. TMR strives to offer guidance to CXOs to undertake mission-critical activities empowered by various business analysis tools, and boost the performance of the organizations. The perspectives guide you to decide on your own marketing mix that align well with the policies, visions, and mission.
  • Strategic Frameworks: The study offers how organizations are setting both short-term and long-term strategic plans. Our team of experts collaborate and communicate with you to understand these to make your organizations sustainable and resilient during tough times. The insights help them decide sustainable competitive advantage for each business units.
  • Benchmarking for Deciding Target Markets and Brand Positioning: The assessments in the study provides a scrutiny of marketing channels and marketing mix. Our various teams work synergistically with you to help identify your actual and potential direct, indirect, and budget competition areas. Additionally, the study helps you decide most effective budgets for various processes and promotional activities. Furthermore, the study guides you to set benchmarks for integrating people and processes with the 4Ps of marketing. Eventually, this will empower you to find out unique propositioning strategies and niches.
  • Business Composability for Sustainability (C-S): Constant strategy planning for sustainability characterizing our C-S framework in the report has become more relevant than before in the face of disruptions caused by pandemics, recessions, boom and bust cycles, and changing geopolitical scenario. The TMR study offers a high level of customization to help you achieve business composability. Composable enterprises are increasingly gaining the attention of CXOs in order to help them combat market volatility. Our analysts and industry experts help you wade through such uncertainties and guide you to become a smart sustainable business in entirety.

The study presents scrutiny of region-specific consumer and technology trends, including the most recent industry dynamics. These broadly cover but not limited to

  • North America, South America, and the Americas
  • Asia Pacific and Japan
  • Europe
  • Latin America
  • Middle East and Africa

The study offers data-driven insights and guidance of several aspects. Some of the more notable questions are:

  • What are the major recent trends that can influence the product life cycle and the RoI?
  • Which regulatory trends shape corporate-level, business-level, and functional-level strategies?
  • Which micromarketing initiatives of leading players will bring in investments?
  • What can be the best framework and tools for PESTLE analysis?
  • Which regions will witness rise in new opportunities?
  • Which are the game-changing technologies being used to capture new revenue streams in the near future?
  • Which operational and tactical frameworks are being adopted by various players in gaining customer loyalty?
  • What is the current and expected intensity of competition the market in the near future?

Disclaimer: This market research study is an ongoing effort and extreme care has been taken to maintain the highest levels of accuracy at all stages. However, in the light of the rapidly evolving business dynamics, some region-specific or other segment-specific changes may take time to be part of the study.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Synthetic Peptides Market